The global postpartum depression management market is set to grow steadily over the next decade, with a projected compound annual growth rate (CAGR) of 3.8% from 2022 to 2032. In 2022, the market is expected to capture a revenue share of USD 115.1 million, with forecasts predicting it will reach USD 173.9 million by 2032.
Postpartum depression, a common and serious condition affecting new mothers worldwide, is driving the demand for effective management solutions. The increasing awareness of mental health, along with the rising availability of treatments such as therapy, medications, and support programs, is boosting the market’s growth. Additionally, advancements in healthcare infrastructure and greater access to postpartum care are contributing to this upward trend.
As the global healthcare industry continues to prioritize mental health, the postpartum depression management market is anticipated to witness steady expansion in the coming years.
Postpartum depression, a prevalent mood disorder observed primarily in expectant mothers but affecting both genders, arises following childbirth. A recent study in a peer-reviewed journal revealed that one in seven women who have recently given birth experiences this condition. Within three weeks of childbirth, the symptoms of depression often become pronounced. In 2022, the postpartum depression management market generated a revenue of US$ 115.1 million and is projected to grow to US$ 173.9 million by 2032.
Postpartum Depression Management Industry Players:
SAGE Therapeutics Inc., Cipla Limited, Sun Pharmaceutical Industries Ltd., Anikem Laboratories, Intas Pharmaceuticals Ltd., and Mylan N.V., among others, represent the global Postpartum Depression Management market. The market study depicts an extensive analysis of all the players running in the Postpartum Depression Management industry report based on distribution channels, local networks, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Postpartum Depression Management industry report.
Future Market Insights, in its latest business report, elaborates on the current situation of the global Postpartum Depression Management industry in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects.
Understanding the Impact of Covid-19 on Healthcare Industry
With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.
The FMI’s latest report on the Postpartum Depression Management industry gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to the pandemic.
Postpartum Depression Management Industry: Segmentation
Segmentation by Treatment Type
- Anti – Depressant Drugs
- New Anti – Depressant Drugs
- SAGE-547
- Bupropion
- Escitalopram
- Fluoxetine
- Paroxetine
- Sertraline
- Old Anti – Depressant Drugs
- Amitriptyline
- Desipramine
- Doxepin
- Tranylcypromine
- Trimipramine
- Psychotherapy
- Interpersonal Psychotherapy (IPT)
- Cognitive Behavioral Therapy (CBT)
- Dialectical Behavioral Therapy (DBT)
- Psychodynamic Psychotherapy
- Eye Movement Desensitization and Reprocessing (EMDR)
- Solution-Focused Brief Psychotherapy
- Group Therapy
- Couples Therapy
Segmentation by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- E-commerce
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
